SCHEMBL7500771

SCHEMBL7500771

Fc1cccc(Cl)c1Cc1cc2ccccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PCSK9 Q8NBP7 5/20 0.53
DAO P14920 2/20 0.51
GUSB P08236 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.46
AHR P35869 1/20 0.44
TAAR1 Q96RJ0 1/20 0.42
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
F2 P00734 1/20 0.40
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
PPP1CA P62136 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7490345 0.89 PCSK9 (0.59) PCSK9GUSBLOXL2AHRF2
SCHEMBL7500314 0.80 PCSK9 (0.50) PCSK9GUSBLOXL2AHR
SCHEMBL7497069 0.79 PCSK9 (0.60) PCSK9GUSBLOXL2AHRF2
SCHEMBL6107658 0.77 PCSK9 (0.48) PCSK9GUSBLOXL2AHRNPC1
SCHEMBL7490425 0.76 PCSK9 (0.63) PCSK9DAOLOXL2AHR
SCHEMBL7491887 0.76 PCSK9 (0.63) PCSK9DAOGUSBLOXL2AHR
SCHEMBL7498462 0.76 PCSK9 (0.63) PCSK9GUSBLOXL2AHRF2
SCHEMBL401081 0.75 LOXL2 (0.69) PCSK9LOXL2AHR
SCHEMBL28338445 0.75 LOXL2 (0.69) PCSK9LOXL2AHR
SCHEMBL29403791 0.75 LOXL2 (0.69) PCSK9LOXL2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244652-A1 2-(1H-INDOL-3-YL)-2-OXO-ACETAMIDES WITH ANTITUMOR ACTIVITY Cell Therapeutics Europe S.R.L. (IT) 2002-10-02 EP disclosed
WO-2001047916-A1 2-(1H-INDOL-3-YL)-2-OXO-ACETAMIDES WITH ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2001-07-05 WO disclosed